What is the official website of Lonza BioResearch Solutions ?

The official website of Lonza BioResearch Solutions is https://bioscience.lonza.com/.

What is Lonza BioResearch Solutions's cybersecurity risk score?

Lonza BioResearch Solutions has an AI-generated cybersecurity risk score of 755 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Lonza BioResearch Solutions experienced?

According to Rankiteo, Lonza BioResearch Solutions currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Lonza BioResearch Solutions been affected by any supply chain cyber incidents ?

According to Rankiteo, Lonza BioResearch Solutions has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Lonza BioResearch Solutions have SOC 2 Type 1 certification ?

According to Rankiteo, Lonza BioResearch Solutions is not certified under SOC 2 Type 1.

Does Lonza BioResearch Solutions have SOC 2 Type 2 certification ?

According to Rankiteo, Lonza BioResearch Solutions does not hold a SOC 2 Type 2 certification.

Does Lonza BioResearch Solutions comply with GDPR ?

According to Rankiteo, Lonza BioResearch Solutions is not listed as GDPR compliant.

Does Lonza BioResearch Solutions have PCI DSS certification ?

According to Rankiteo, Lonza BioResearch Solutions does not currently maintain PCI DSS compliance.

Does Lonza BioResearch Solutions comply with HIPAA ?

According to Rankiteo, Lonza BioResearch Solutions is not compliant with HIPAA regulations.

Does Lonza BioResearch Solutions have ISO 27001 certification ?

According to Rankiteo,Lonza BioResearch Solutions is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Lonza BioResearch Solutions operate in ?

Lonza BioResearch Solutions operates primarily in the Biotechnology Research industry.

How many employees does Lonza BioResearch Solutions have ?

Lonza BioResearch Solutions employs approximately None employees people worldwide.

Does Lonza BioResearch Solutions own any subsidiaries ?

Lonza BioResearch Solutions presently has no subsidiaries across any sectors.

How many LinkedIn followers does Lonza BioResearch Solutions have ?

Lonza BioResearch Solutions's official LinkedIn profile has approximately 11,842 followers.

What is the NAICS classification code for Lonza BioResearch Solutions ?

Lonza BioResearch Solutions is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Lonza BioResearch Solutions have a Crunchbase profile ?

No, Lonza BioResearch Solutions does not have a profile on Crunchbase.

Does Lonza BioResearch Solutions have a LinkedIn profile ?

Yes, Lonza BioResearch Solutions maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/lonza-bioresearch-solutions.

How many cybersecurity incidents has Lonza BioResearch Solutions experienced ?

As of September 28, 2026, Rankiteo reports that Lonza BioResearch Solutions has not experienced any cybersecurity incidents.

How many peer or competitor companies does Lonza BioResearch Solutions have ?

Lonza BioResearch Solutions has an estimated 4,775 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

LBS

Boost Score +25 with badge (5 left)

755

/1000

Fair

780

/1000

Fair

Lonza BioResearch Solutions Vendor Cyber Rating & Cyber Score

lonza.com

Add Your Compliance Badge

Lonza Bioscience Solutions serves research customers globally in pharmaceutical, biopharmaceutical, biotechnology and personal care companies, as well as academic and government research institutions.

LBS

Lonza BioResearch Solutions CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

LBS Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for LBS

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Lonza BioResearch Solutions in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Lonza BioResearch Solutions in 2026.

Incident Types LBS vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Lonza BioResearch Solutions in 2026.

Incident History - LBS (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Lonza BioResearch Solutions Subsidiaries

LBS

Biotechnology Research

Website: https://bioscience.lonza.com/

Company Size: None employees

LonzaPharmaceutical Manufacturing

Lonza Testing SolutionsBiotechnology Research

Lonza Capsules & Health IngredientsPharmaceutical Manufacturing

Lonza MODA®- Informatics Solutions for QC & ManufacturingSoftwareentwicklung

Loading…

Lonza BioResearch Solutions Similar Companies

Genentech

gene.com

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or [email protected]. Community Guidelines: 1. We want to foster positive conversation around the issues we are passionate about. To that end, we remove profanity, content that contains threatening language, content that is aimed at private individuals, personal information, and repeated unwanted messages. 2. Don’t mention any medicines by name — ours or anyone else’s. Because of the fair balance rules governing our industry, we cannot post any comments that reference any pharmaceutical brand, product, or service. Please do not mention any specific medicines by name, or include any links to third party sites in your comments. 3. This isn’t the place to report or discuss side effects. This site is not intended as a forum for reporting side effects experienced while taking a Genentech product. Instead, you should report any side effects to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription product directly to the FDA at 1-800-FDA-1088 or by visiting www.FDA.gov/medwatch. 4. Don’t pitch your product or service. Please don't use our page as a place to promote your product or pitch your services. Please also avoid posting links to external sites. We reserve the right to remove any posts that are deemed promotional.

Amgen

amgen.com

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Thermo Fisher Scientific

thermofisher.com

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Roche

cb roche.com

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

Avantor

cb avantorsciences.com

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Syneos Health

cb syneoshealth.com

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

Loading…

NEWS

Lonza BioResearch Solutions CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-96284

SUMMARY

A malicious user can get read-access to files in the flatpak-system-helper context if a system OCI repository is configured, because the OCI code paths in the system helper follow symlinks when importing OCI images that are under the user's control.

Published

Date2026-09-27

Updated

Date2026-09-27

RISK INFORMATION (Score: 2.5)

cvss3

Base Score: 2.5

Complexity: HIGH

CVSS:3.1/AV:L/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N

Impact Score

1.4

Exploitability

REFERENCES

CVE-2026-100886

SUMMARY

A vulnerability was identified in Seetong T8108, T8108P, T8116 and T8232 4.6.1.4-build202604241011. The affected element is an unknown function of the component Debug Service. Such manipulation leads to improper authentication. The attack may be launched remotely. The exploit is publicly available and might be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-27

Updated

Date2026-09-27

RISK INFORMATION (Score: 10)

cvss2

Base Score: 10.0

Complexity: LOW

AV:N/AC:L/Au:N/C:C/I:C/A:C

cvss3

Base Score: 10.0

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

3.9

REFERENCES

CVE-2026-100885

SUMMARY

A vulnerability was found in Krayin laravel-crm up to 2.2.4. This affects an unknown function of the file packages/Webkul/Installer/src/Http/Middleware/CanInstall.php of the component admin-config-setup API Endpoint. The manipulation results in authorization bypass. The attack may be launched remotely. The exploit has been made public and could be used. Upgrading to version 2.2.5 mitigates this issue. The patch is identified as 89f2916b6a46ff91bd1999ce38158fa0de8b9490. Upgrading the affected component is recommended.

Published

Date2026-09-27

Updated

Date2026-09-27

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

CVE-2026-100884

SUMMARY

A vulnerability has been found in Krayin laravel-crm up to 2.2.5. The impacted element is the function Storage::download of the file packages/Webkul/Admin/src/Config/acl.php of the component attachment-download Endpoint. The manipulation of the argument ID leads to improper control of resource identifiers. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used. Upgrading to version 2.2.6 is sufficient to resolve this issue. The identifier of the patch is 13d6988cda8d69ece45ee1890effc90a7f21cdc1. It is suggested to upgrade the affected component.

Published

Date2026-09-27

Updated

Date2026-09-27

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 4.0

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:N/A:N

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-100883

SUMMARY

A flaw has been found in Krayin laravel-crm up to 2.2.5. The affected element is an unknown function of the file packages/Webkul/Admin/src/Config/acl.php. Executing a manipulation can lead to improper access controls. The attack can be launched remotely. The exploit has been published and may be used. Upgrading to version 2.2.6 is sufficient to fix this issue. This patch is called a399404a388d8ad2700a01349d0d98069c8e85a4. The affected component should be upgraded.

Published

Date2026-09-27

Updated

Date2026-09-27

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Lonza BioResearch Solutions Vendor Cyber Rating & Cyber Score

LBS A.I CyberSecurity Scoring

Lonza BioResearch Solutions CyberSecurity News & History

LBS Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for LBS

Incidents vs Biotechnology Research Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types LBS vs Biotechnology Research Industry Avg (This Year)

Incident History - LBS (X = Date, Y = Severity)

Lonza BioResearch Solutions Subsidiaries

LBS

Lonza BioResearch Solutions Similar Companies

Genentech

Amgen

Eurofins

CSL

Thermo Fisher Scientific

Roche

Avantor

ICON plc

Syneos Health

Lonza BioResearch Solutions CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Lonza BioResearch Solutions CyberSecurity News & History

LBS Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for LBS

Incidents vs Biotechnology Research Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types LBS vs Biotechnology Research Industry Avg (This Year)

Incident History - LBS (X = Date, Y = Severity)

Lonza BioResearch Solutions Subsidiaries

LBS

Lonza BioResearch Solutions Similar Companies

Genentech

Amgen

Eurofins

CSL

Thermo Fisher Scientific

Roche

Avantor

ICON plc

Syneos Health

Lonza BioResearch Solutions CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo